Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
432.00
+0.05 (0.01%)
At close: Mar 28, 2025, 4:00 PM
431.60
-0.40 (-0.09%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Elevance Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 5,980 | 5,987 | 5,894 | 6,158 | 4,572 | Upgrade
|
| Depreciation & Amortization | 659 | 1,060 | 1,076 | 817 | 742 | Upgrade
|
| Other Amortization | 734 | 685 | 599 | 485 | 412 | Upgrade
|
| Gain (Loss) on Sale of Assets | -201 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 191 | 289 | 264 | 255 | 283 | Upgrade
|
| Change in Accounts Receivable | -683 | -1,762 | -2,510 | -2,138 | -256 | Upgrade
|
| Change in Accounts Payable | -272 | 1,640 | 824 | 719 | 1,978 | Upgrade
|
| Change in Unearned Revenue | -113 | 290 | -42 | -113 | 202 | Upgrade
|
| Change in Income Taxes | 404 | -103 | -338 | 140 | 72 | Upgrade
|
| Change in Insurance Reserves / Liabilities | -1,840 | 147 | 2,411 | 2,523 | 3,528 | Upgrade
|
| Change in Other Net Operating Assets | 785 | -747 | 78 | -8 | -270 | Upgrade
|
| Other Operating Activities | 62 | 96 | 429 | 15 | -722 | Upgrade
|
| Operating Cash Flow | 5,808 | 8,061 | 8,399 | 8,364 | 10,688 | Upgrade
|
| Operating Cash Flow Growth | -27.95% | -4.02% | 0.42% | -21.74% | 76.34% | Upgrade
|
| Capital Expenditures | -1,256 | -1,296 | -1,152 | -1,087 | -1,021 | Upgrade
|
| Cash Acquisitions | -4,809 | -1,552 | -649 | -3,476 | -1,976 | Upgrade
|
| Investment in Securities | 586 | -2,700 | -2,338 | -4,056 | -3,433 | Upgrade
|
| Other Investing Activities | -51 | -24 | -421 | -1,019 | -894 | Upgrade
|
| Investing Cash Flow | -5,167 | -5,572 | -4,560 | -9,638 | -7,324 | Upgrade
|
| Short-Term Debt Issued | 275 | 339 | 2,600 | 2,331 | 2,305 | Upgrade
|
| Long-Term Debt Issued | 7,710 | 2,574 | 3,071 | 3,462 | 2,484 | Upgrade
|
| Total Debt Issued | 7,985 | 2,913 | 5,671 | 5,793 | 4,789 | Upgrade
|
| Total Debt Repaid | -2,498 | -2,251 | -3,574 | -2,494 | -3,752 | Upgrade
|
| Net Debt Issued (Repaid) | 5,487 | 662 | 2,097 | 3,299 | 1,037 | Upgrade
|
| Issuance of Common Stock | 221 | 152 | 182 | 203 | 176 | Upgrade
|
| Repurchases of Common Stock | -3,009 | -2,775 | -2,409 | -2,002 | -2,828 | Upgrade
|
| Common Dividends Paid | -1,508 | -1,395 | -1,229 | -1,104 | -954 | Upgrade
|
| Other Financing Activities | 2 | 7 | 41 | 27 | 2 | Upgrade
|
| Financing Cash Flow | 1,193 | -3,349 | -1,318 | 423 | -2,567 | Upgrade
|
| Foreign Exchange Rate Adjustments | -6 | -1 | -14 | -10 | 7 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -66 | - | - | - | - | Upgrade
|
| Net Cash Flow | 1,762 | -861 | 2,507 | -861 | 804 | Upgrade
|
| Free Cash Flow | 4,552 | 6,765 | 7,247 | 7,277 | 9,667 | Upgrade
|
| Free Cash Flow Growth | -32.71% | -6.65% | -0.41% | -24.72% | 93.96% | Upgrade
|
| Free Cash Flow Margin | 2.57% | 3.95% | 4.63% | 5.25% | 7.93% | Upgrade
|
| Free Cash Flow Per Share | 19.55 | 28.50 | 29.85 | 29.48 | 38.01 | Upgrade
|
| Cash Interest Paid | 1,239 | 1,032 | 878 | 822 | 794 | Upgrade
|
| Cash Income Tax Paid | 1,303 | 1,936 | 1,594 | 1,299 | 1,790 | Upgrade
|
| Levered Free Cash Flow | 6,921 | 624.88 | 8,425 | 3,614 | 6,741 | Upgrade
|
| Unlevered Free Cash Flow | 7,661 | 1,269 | 8,960 | 4,115 | 7,232 | Upgrade
|
| Change in Net Working Capital | -1,585 | 5,650 | -2,884 | 1,997 | -1,653 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.